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Whether to
perform live case
demonstrations or
not will continue to
be discussed, but my
view is that, as
diligent as we
must be to avoid
complications,
it is from these
adversities that we
learn the most.The discussion of whether interventional cases should be demonstrated and transmitted is as old as
interventional cardiology itself. In fact, it precedes interventional cardiology, as the surgical
“theater” was indeed a place for the “show.” Demonstration has been accepted as a critical
component of the educational process in our specialty. The dual objectives of live case
demonstration, the care of the patient, and the instruction of others, are not a balanced goal,
because the care of the patient must always be primary. I have discussed this topic in this space
previously (1), and attempts at studying the safety and value (2) have generally come down on the
side of the worth of live cases, although such assessments are perhaps not without some bias. I have
been witness to situations in which the safety of the patient did not seem to have been the primary
goal, and this should never be repeated.
Believing that there is educational value in live case demonstrations, the American College of
Cardiology began a monthly broadcast of such cases from Mount Sinai Hospital in New York 1
year ago. These cases are widely viewed, and recently I was invited to return to Mount Sinai to
participate in the 1-year anniversary procedure, to be performed by Drs. Samin Sharma and
Annapoorna Kini. These high-volume operators often make complex cases look easy, given their
expertise and the high-performance technology that is available to us. Indeed, many live cases
performed in training courses around the world look pretty routine. On this day, there was to be
nothing routine. The selection of the patient was appropriate: a patient with signiﬁcant angina
pectoris who had severe in-stent restenosis and a drug-eluting stent placed in the proximal left
anterior descending coronary artery (LAD) 7 years previously. Surgery had been performed even
earlier, and the grafts, including the left internal mammary artery to the LAD, had all become
occluded. Revascularization was needed for refractory symptoms, and repeat surgery was possible
but problematic because the internal mammary artery was no longer available. The very late
restenosis (7 years) raised the question of whether this could represent neoatherosclerosis. Imaging
with intravascular ultrasound and near-infrared catheterization established that there was complete
expansion of the stent and signiﬁcant lipid content. Optical coherence tomography showed a thin
ﬁbrous cap over the in-stent restenotic lesion. Whereas intravascular ultrasound is needed for the
evaluation of in-stent restenosis to establish if stent underexpansion is a problem, the investigation
of possible neoatherosclerosis is in its early evolution, and how to change the approach to such
lesions is unknown. The details of the case can be viewed on CardioSource.org, but the ﬁrst
inﬂation of the balloon in the lesion led to occlusion of the circumﬂex and ultimately poor
perfusion of the left system. Re-establishing ﬂow was extremely difﬁcult, and deteriorating
hemodynamic status necessitated simultaneous insertion of a balloon pump by a second team while
attempts at restoring ﬂow continued. Further deterioration led to profound hypotension, cardiac
arrest, cardiopulmonary resuscitation, deﬁbrillation, enlisting anesthesia support, and surgical
establishment of extracorporeal membrane oxygenation. With improvement of hemodynamic
status, the left coronary system patency could be restored, and the patient began to stabilize.
This patient would not have survived this complication in hospitals without comprehensive
support of personnel and equipment that was available. So what is to be learned from a live case
demonstration? Should they be done, or should only well-crafted teaching points be shown? As I
left the laboratory to allow room for the surgeons to work, I was asked to comment on the case, not
at all sure of the outcome. I related another live case from more than 32 years ago. It was the last
procedure in the ﬁrst course at Emory. Andreas Gruentzig was the operator, and I was moderating
in front of an audience of aspiring interventionalists. The patient had a severe but discrete lesion
about 2 cm down the LAD. Nothing else. Andreas said that for those who were starting
angioplasty, this is the kind of case they should choose. It was easily accessible to the ﬁxed-wire
Gruentzig balloon, which could hardly be directed at all, and often dependent on aiming the
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896guiding catheter toward the LAD or circumﬂex artery.
The lesion was short, and therefore balloon dilation
should have cracked and displaced it nicely, leaving an
adequate lumen. With the ﬁrst balloon inﬂation, there
was no ﬂow down the LAD. Shortly thereafter,
hypotension and ventricular ﬁbrillation ensued. I
remember the audience’s response was a collective
gasp, even if inaudible. As the paddles came out to
perform deﬁbrillation, I cut the transmission, and off
the patient went to the operating room. Later, when
Andreas rejoined me in the auditorium, we reﬂected
on what happened. We always believed that this case
may have been the most educational of the course. We
speculated that a signiﬁcant number of people in the
room would decide that interventional cardiology was
not for them, and that may have been a blessing.
What value was provided by this live case
demonstration? Would it have happened if the case
had not been transmitted? I think what was learned, as
has been learned by all experienced operators, was that
we must expect the unexpected. In the early days,
complications were frequent, and therefore this lesson
was constantly being reinforced. Now most cases, even
at live demonstration courses, go smoothly, and the
impression may be given that interventional cardiology
is easy. It has always been clear to me that the lack of
complications in routine situations is not an adequate
measure of quality. It is in the most difﬁcult and
unexpected settings that operators and systems are
really tested. I have landed a commercial jetliner(actually a simulator) under controlled conditions.
I am sure the passengers on Captain Chesley
Sullenberger’s plane were appreciative of the training,
skills, and systems in place enabling him to land safely
in the Hudson River.
None of us want to encounter a case like the one at
Mount Sinai Hospital, but it is always lurking out
there. Fortunately, the news is good. The patient
“miraculously” recovered and was eventually
discharged in good shape. The miracle, however, was
possible only because of a well-developed system to
cope with the unexpected. Whether to perform live
case demonstrations or not will continue to be
discussed, but my view is that, as diligent as we must
be to avoid complications, it is from these adversities
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